Skip to main content

Sub menu

News and Community
About us

Search

Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources
News and Community
About us

You are here

Home
Guidance and resources

Medis Pharma Pty Ltd

Regulatory activities for this sponsor.

Loading...

Cancellation by sponsor (1412) Cancellation by sponsor (1412)
ARTG (108) ARTG (108)
Cancellation or suspension (26) Cancellation or suspension (26)
Listed medicine compliance report (5)
Prescription medicine registration (2)

2025 (13) 2025 (13)
2024 (1215) 2024 (1215)
2023 (3) 2023 (3)
2022 (29) 2022 (29)
2021 (106) 2021 (106)
2020 (31) 2020 (31)
2019 (6) 2019 (6)
2018 (5) 2018 (5)
2017 (47) 2017 (47)
2016 (5) 2016 (5)
2015 (29) 2015 (29)
2014 (23) 2014 (23)
2013 (17) 2013 (17)
2012 (9) 2012 (9)
2011 (10) 2011 (10)
2010 (3) 2010 (3)
2009 (2) 2009 (2)

Search

Sponsor content

1553 result(s) found, displaying 1 to 10

DESVENLAFAXINE MEDIS desvenlafaxine 50mg modified release tablets bottle Cancelled under Section 30(1)(c) of the Act

27 March 2025

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
DESVENLAFAXINE MEDIS desvenlafaxine 50mg modified release tablets blister Cancelled under Section 30(1)(c) of the Act

27 March 2025

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
DESVENLAFAXINE MEDIS desvenlafaxine 100mg modified release tablets blister Cancelled under Section 30(1)(c) of the Act

27 March 2025

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
DESVENLAFAXINE MEDIS desvenlafaxine 100mg modified release tablets bottle Cancelled under Section 30(1)(c) of the Act

27 March 2025

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
FENPATCH 50 fentanyl 50 mcg/hr transdermal patch pouch Cancelled under Section 30(1)(c) of the Act

18 March 2025

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
FENPATCH 75 fentanyl 75 mcg/hr transdermal patch pouch Cancelled under Section 30(1)(c) of the Act

18 March 2025

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
FENPATCH 25 fentanyl 25 mcg/hr transdermal patch pouch Cancelled under Section 30(1)(c) of the Act

18 March 2025

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
FENPATCH 100 fentanyl 100 mcg/hr transdermal patch pouch Cancelled under Section 30(1)(c) of the Act

18 March 2025

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
FENPATCH 12 fentanyl 12 mcg/hr transdermal patch pouch Cancelled under Section 30(1)(c) of the Act

18 March 2025

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
OMEPRAZOLE-WGR omeprazole 20 mg enteric-coated tablet blister (444390)

2 January 2025

ARTG

Australian Register of Therapeutic Goods (ARTG) information for OMEPRAZOLE-WGR omeprazole 20 mg enteric-coated tablet blister.

Pages

Current page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Is there anything wrong with this page?

Help us improve this page

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control - external site
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook - external site
(formerly Twitter) - external site
Youtube - external site
Instagram - external site
LinkedIn - external site

Help us improve

We are always looking for ways to improve our website.

Provide feedback - external site

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.

© Commonwealth of Australia